Mezquita P, Beard B C, Kiem H-P
Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA 98109-1024, USA.
Gene Ther. 2008 Nov;15(21):1460-2. doi: 10.1038/gt.2008.108. Epub 2008 Jun 19.
We have previously compared the repopulation ability of gene-modified baboon CD34+ cells in an autologous transplantation versus a xenotransplant model in irradiated nonobese diabetic/severe combined immune deficiency (NOD/SCID) mice. Baboon CD34-selected marrow cells were transduced with a gammaretrovirus vector and infused into irradiated baboons and NOD/SCID mice. A limited integration-site analysis could only detect two common retrovirus integration sites in the NOD/SCID and monkey. Here, we performed locus-specific PCR on 30 clones recovered from NOD/SCID beta2-microglobulin mice reconstituted with transduced baboon CD34+ cells. We identified five common integrants in the baboon early after transplant (2-6 weeks) but none during the long-term follow-up (6 and 12 months). These results confirm that repopulating cells in the NOD/SCID mouse contribute only to short-term repopulation in a clinically relevant large animal model.
我们之前比较了基因修饰的狒狒CD34+细胞在自体移植与异种移植模型中,于经辐照的非肥胖糖尿病/重症联合免疫缺陷(NOD/SCID)小鼠体内的再增殖能力。用γ逆转录病毒载体转导狒狒CD34选择的骨髓细胞,并将其注入经辐照的狒狒和NOD/SCID小鼠体内。有限的整合位点分析仅能在NOD/SCID小鼠和猴子中检测到两个常见的逆转录病毒整合位点。在此,我们对从用转导的狒狒CD34+细胞重建的NOD/SCIDβ2-微球蛋白小鼠中回收的30个克隆进行了位点特异性PCR。我们在移植后早期(2 - 6周)的狒狒中鉴定出五个常见的整合体,但在长期随访(6个月和12个月)期间未发现。这些结果证实,在NOD/SCID小鼠中的再增殖细胞仅在临床相关的大型动物模型中促成短期再增殖。